Extreme Prematurity
33
4
7
19
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 33 trials
100.0%
+13.5% vs benchmark
6%
2 trials in Phase 3/4
21%
4 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (33)
NICU Antibiotics and Outcomes Trial
Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
LISA in the Delivery Room for Extremely Preterm Infants
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
Improve the Survival Without Morbidity of Extremely Preterm Infants (PREMEX)
Single-dose Prophylactic INdomethacin in Extremely Preterm Infants
Ventilator Pressure and Optimization of Compliance and Hemodynamics
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants
Prediction of Brain Injury in Premature Infants
Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia
Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Preterm Infants
SafeBoosC III Two-year Follow-up
Canadian National PDA Treatment Study
Folic Acid Supplementation to Reduce Anemia in Extremely Preterm Infants
Stockholm Preterm Interaction-Based Intervention
Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA
Time to Accurate Heart Rate on Neonatal Outcomes
Early Intervention Based on Neonatal Crawling in Very Premature Infants at Risk For Neurodevelopmental Disorder
PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)